Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The LIPid Intensive Drug Therapy for Sepsis ¬Pilot (LIPIDS-P) Phase I/II Trial

Trial Profile

The LIPid Intensive Drug Therapy for Sepsis ¬Pilot (LIPIDS-P) Phase I/II Trial

Phase of Trial: Phase I/II

Latest Information Update: 06 Dec 2018

At a glance

  • Drugs Soya oil emulsion/medium-chain triglyceride/olive oil/fish oil (Primary)
  • Indications Sepsis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms LIPIDS-P
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 17 Aug 2018 Planned number of patients changed from 64 to 84.
    • 17 Aug 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top